Literature DB >> 15464659

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.

Stephen A Harrison1, Brent A Neuschwander-Tetri.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is a well-recognized form of chronic liver disease affecting both children and adults that has gained increased recognition. Recently NAFLD has been associated with insulin resistance and its incidence and prevalence is likely increasing, paralleling the rise in obesity and diabetes mellitus in the United States. The article includes current thoughts on the natural history and pathogenesis of NAFLD and describes current trends in the diagnosis and treatment of this condition.

Entities:  

Mesh：

Year:  2004        PMID： 15464659     DOI： 10.1016/j.cld.2004.06.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN： 1089-3261            Impact factor:   6.126


  39 in total

1.  Generalizability of the nonalcoholic steatohepatitis Clinical Research Network histologic scoring system for nonalcoholic fatty liver disease.

Authors:  Ravi Juluri; Raj Vuppalanchi; John Olson; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; James Tonascia; Naga Chalasani
Journal:  J Clin Gastroenterol       Date:  2011-01       Impact factor: 3.062

2.  PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.

Authors:  Elizabeth K Speliotes; Johannah L Butler; Cameron D Palmer; Benjamin F Voight; Joel N Hirschhorn
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

3.  Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis.

Authors:  Cindy X Cai; Hema Buddha; Shobha Castelino-Prabhu; Zhiwei Zhang; Robert S Britton; Bruce R Bacon; Brent A Neuschwander-Tetri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

4.  Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.

Authors:  Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

5.  Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude.

Authors:  Hidekatsu Kuroda; Keisuke Kakisaka; Naohisa Kamiyama; Takayoshi Oikawa; Mio Onodera; Kei Sawara; Kanta Oikawa; Ryujin Endo; Yasuhiro Takikawa; Kazuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

6.  Automated two-point dixon screening for the evaluation of hepatic steatosis and siderosis: comparison with R2-relaxometry and chemical shift-based sequences.

Authors:  B Henninger; H Zoller; S Rauch; M Schocke; S Kannengiesser; X Zhong; G Reiter; W Jaschke; C Kremser
Journal:  Eur Radiol       Date:  2014-12-14       Impact factor: 5.315

7.  Nonalcoholic Steatohepatitis: Clinical Presentation, Diagnosis, and Treatment.

Authors:  Joel Z Stengel; Stephen A Harrison
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-06

8.  Liver fat volume fraction quantification with fat and water T1 and T 2* estimation and accounting for NMR multiple components in patients with chronic liver disease at 1.5 and 3.0 T.

Authors:  Benjamin Leporq; Hélène Ratiney; Frank Pilleul; Olivier Beuf
Journal:  Eur Radiol       Date:  2013-04-16       Impact factor: 5.315

9.  Liver fat is reproducibly measured using computed tomography in the Framingham Heart Study.

Authors:  Elizabeth K Speliotes; Joseph M Massaro; Udo Hoffmann; Meredith C Foster; Dushyant V Sahani; Joel N Hirschhorn; Christopher J O'Donnell; Caroline S Fox
Journal:  J Gastroenterol Hepatol       Date:  2008-06       Impact factor: 4.029

Review 10.  The metabolic syndrome and nonalcoholic fatty liver disease in children.

Authors:  Shikha S Sundaram; Phil Zeitler; Kristen Nadeau
Journal:  Curr Opin Pediatr       Date:  2009-08       Impact factor: 2.856
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.